SINOVA-M-14034 C-Reactive Protein (CRP) Quantitative Test Kit

Clinical Significance: As an extremely sensitive indicator of the acute phase response, plasma CRP concentration can rapidly and significantly increase up to 2000 times the normal level in cases of acute myocardial infarction, trauma, infection, inflammation, surgery, and cancer infiltration. Combined with clinical history, it helps in monitoring disease progression, especially in inflammatory processes, and in following up on conditions such as rheumatism, systemic lupus erythematosus, and leukemia.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
 
Usage Scenarios:
Hospitals and Clinics: For diagnosing and monitoring acute phase responses in conditions such as acute myocardial infarction, trauma, infection, inflammation, surgery, and cancer infiltration.
Rheumatology Departments: For monitoring disease progression in inflammatory conditions like rheumatism and systemic lupus erythematosus.
Oncology Departments: For tracking inflammation and cancer infiltration.
Diagnostic Laboratories: For routine testing of C-reactive protein (CRP) levels to assess and monitor inflammatory processes.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic services are in demand for managing various acute and chronic conditions.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are expanding and investing in modern diagnostic tools to enhance patient care.
Global Health Programs: International health initiatives focused on improving diagnostic capabilities and disease monitoring in low-resource settings.